glp-1/gip treatment Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research How Three Types of GLP-1

The PA criteria require BMI 30 or higher (or 27 with a comorbidity such as type 2 diabetes, hypertension, dyslipidemia, OSA, or CVD), documentation of a 6-month structured weight management program, prescriber attestation that lifestyle change alone has failed, and age 18 or older

Model et al., 2024)

Research shows that low B12 levels are associated with increased body fat, disrupted fat processing and insulin resistance, highlighting its role in maintaining metabolic balance

In 2006, Competitive Technologies, a technology transfer company operating on behalf of the University of Arizona, licensed the drug as a tanning agent